Radioimmunoassay for human follicle-stimulating hormone: physiological studies.

Area of Science:

• Endocrinology
• Reproductive Biology
• Hormone Assays

Background:

• Traditional bioassays for follicle-stimulating hormone (FSH) are insensitive and require large urine sample volumes.
• Existing immunoassays often struggle to differentiate between FSH, luteinizing hormone (LH), and thyroid-stimulating hormone (TSH) due to hormonal similarities.

Purpose of the Study:

• To develop a highly sensitive and specific radioimmunoassay (RIA) for quantifying FSH in human serum.
• To establish normal serum FSH ranges in eugonadal and hypogonadal men and women, and to characterize FSH patterns during the menstrual cycle.

Main Methods:

• Development of a specific anti-FSH antiserum for RIA.
• Validation of the RIA against bioassay results for FSH-containing preparations.
• Measurement of serum FSH levels in men, women across the menstrual cycle, postmenopausal women, and children.

Main Results:

• The developed RIA is 500-1000 times more sensitive than the rat ovarian weight augmentation bioassay.
• Serum FSH levels varied significantly with gonadal status (eugonadal vs. castrate/postmenopausal) and menstrual cycle phase.
• Oral contraceptives suppressed FSH levels, while estrogen treatment in castrates reduced FSH but did not eliminate it.

Conclusions:

• The novel RIA provides a sensitive and specific method for measuring serum FSH.
• The assay facilitates detailed characterization of FSH secretion dynamics in various physiological and pathological conditions.
• Understanding FSH levels is crucial for reproductive health and endocrine disorder diagnosis.